Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalities.
暂无分享,去创建一个
H. Kantarjian | J. Cortes | A. Quintás-Cardama | S. Verstovsek | P. Jain | F. Ravandi | G. Borthakur | E. Jabbour | S. Pierce | S. O'brien | A. Nazha | C. Romo | M. Cárdenas-Turanzas | A. Quintás-Cardama